[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67230-67231]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21459]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-52-2023]


Foreign-Trade Zone (FTZ) 46, Notification of Proposed Production 
Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); 
Cincinnati, Ohio

    Patheon Pharmaceuticals Inc. (Patheon) submitted a notification of 
proposed production activity to the FTZ Board (the Board) for its 
facilities in Cincinnati, Ohio, within Subzone 46K. The notification 
conforming to the requirements of the Board's regulations (15 CFR 
400.22) was received on September 18, 2023.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz. The proposed finished 
product(s) and material(s)/component(s) would be added to the 
production authority that the Board previously approved for the 
operation, as reflected on the Board's website.
    The proposed finished product is cancer treatment (active 
pharmaceutical ingredient--regorafenib) in finished dosage form (duty-
free).
    The proposed material/component is regorafenib active 
pharmaceutical ingredient (duty-free). The request indicates that the 
material/component is subject to duties under section 301 of the Trade 
Act of 1974 (section 301), depending on the country of origin. The 
applicable section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is November 8, 
2023.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    FOR FURTHER INFORMATION, contact Diane Finver at 
[email protected].


[[Page 67231]]


    Dated: September 26, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-21459 Filed 9-28-23; 8:45 am]
BILLING CODE 3510-DS-P